Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
381,436
-
Shares change
-
+24,956
-
Total reported value, excl. options
-
$609,000
-
Value change
-
+$39,267
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$1.60
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q2 2016
10 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q2 2016.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 381,436 shares
of 48,041,653 outstanding shares and own 0.79% of the company stock.
Largest 10 shareholders include CREDIT SUISSE AG/ (220,548 shares), VANGUARD GROUP INC (69,570 shares), BlackRock Institutional Trust Company, N.A. (33,039 shares), CITADEL ADVISORS LLC (18,785 shares), TWO SIGMA SECURITIES, LLC (13,141 shares), PNC FINANCIAL SERVICES GROUP, INC. (10,000 shares), PERKINS CAPITAL MANAGEMENT INC (10,000 shares), UBS Group AG (4,568 shares), BlackRock Fund Advisors (1,785 shares), and Tower Research Capital LLC (TRC) (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.